Phase II Study of Etoposide in the Treatment of Esophageal Carcinoma
Overview
Authors
Affiliations
Tanaka Y, Yoshida K, Yamada A, Tanahashi T, Okumura N, Matsuhashi N Cancer Chemother Pharmacol. 2016; 77(6):1143-52.
PMID: 26896963 PMC: 4882360. DOI: 10.1007/s00280-016-2985-y.
Esophageal cancer chemotherapy: recent advances.
Ilson D Gastrointest Cancer Res. 2009; 2(2):85-92.
PMID: 19259300 PMC: 2630822.
Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus.
Heath E, Urba S, Marshall J, Piantadosi S, Forastiere A Invest New Drugs. 2002; 20(1):95-9.
PMID: 12003198 DOI: 10.1023/a:1014476602804.
Slabber C, FALKSON G, Burger W, Schoeman L Invest New Drugs. 1996; 14(4):391-4.
PMID: 9157075 DOI: 10.1007/BF00180816.
Kok T, van der Gaast A, Dees J, Eykenboom W, van Overhagen H, Stoter G Br J Cancer. 1996; 74(6):980-4.
PMID: 8826870 PMC: 2074745. DOI: 10.1038/bjc.1996.469.